|
Open reading frame (ORF) annotation in the exon skipping event | |
3'-UTR located exon skipping events lost miRNA binding sites | |
Splicing Quantitative Trait Loci (sQTLs) in the skipped exons | |
Gene summary for MARK2 |
Gene summary |
Gene information | Gene symbol | MARK2 | Gene ID | 2011 |
Gene name | microtubule affinity regulating kinase 2 | |
Synonyms | EMK-1|EMK1|PAR-1|Par-1b|Par1b | |
Cytomap | 11q13.1 | |
Type of gene | protein-coding | |
Description | serine/threonine-protein kinase MARK2ELKL motif kinase 1MAP/microtubule affinity-regulating kinase 2PAR1 homolog bSer/Thr protein kinase PAR-1Bserine/threonine protein kinase EMKtesticular tissue protein Li 117 | |
Modification date | 20200329 | |
UniProtAcc | A0A024R555, | |
Context | - 30930738(Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes) |
Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Gene | GO ID | GO term | PubMed ID |
MARK2 | GO:0006468 | protein phosphorylation | 14976552 |
MARK2 | GO:0010976 | positive regulation of neuron projection development | 12429843 |
MARK2 | GO:0018105 | peptidyl-serine phosphorylation | 10542369|16717194 |
MARK2 | GO:0030010 | establishment of cell polarity | 12429843 |
MARK2 | GO:0035556 | intracellular signal transduction | 14976552 |
MARK2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 15324659 |
MARK2 | GO:0070507 | regulation of microtubule cytoskeleton organization | 10542369 |
Top |
Gene structures and expression levels for MARK2 |
Skipped exons in the ROSMAP, MSBB, and Mayo based on Ensembl gene isoform structure. * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Differentially expressed gene analysis across multiple brain tissues between AD and control. |
Tissue type | DEG direction | Base mean exp. | log2FC(AD/control) | P-value | Adj. p-value |
Differentially expressed isoform analysis across multiple brain tissues between AD and control. |
Tissue type | DEG direction | ENST | Transcript info. | Base mean exp. | log2FC(AD/control) | P-value | Adjc. p-value |
CB | UP | ENST00000350490.11 | MARK2-201:protein_coding:MARK2 | 2.696761e+02 | 8.311876e-01 | 5.519004e-13 | 9.127737e-11 |
Landscape of isoform expressions across multiple brain tissues between AD and control. |
Top |
Exon skipping events with PSIs in ROSMAP, MSBB, and Mayo for MARK2 |
Landscape of individual exon skipping event across AD tissues and controls (PSI heatmap). |
All exon skipping events in AD cohorts. |
Exon skip ID | chr | Exons involved in exon skipping | Skipped exon |
exon_skip_116275 | chr11 | 63903061:63903158:63903986:63904147:63904786:63904921 | 63903986:63904147 |
exon_skip_117686 | chr11 | 63904786:63905043:63906088:63906114:63908260:63908304 | 63906088:63906114 |
exon_skip_177197 | chr11 | 63902198:63902330:63902604:63902782:63903061:63903132 | 63902604:63902782 |
exon_skip_216159 | chr11 | 63898232:63898280:63898608:63898673:63898763:63898793 | 63898608:63898673 |
exon_skip_225232 | chr11 | 63906088:63906114:63908260:63908304:63908877:63909237 | 63908260:63908304 |
exon_skip_239346 | chr11 | 63902198:63902330:63902601:63902782:63903061:63903132 | 63902601:63902782 |
exon_skip_281693 | chr11 | 63900780:63900879:63900957:63901069:63902198:63902330 | 63900957:63901069 |
exon_skip_286481 | chr11 | 63895580:63895633:63898232:63898280:63898608:63898673 | 63898232:63898280 |
exon_skip_289284 | chr11 | 63903061:63903158:63903986:63904147:63904786:63905043 | 63903986:63904147 |
exon_skip_78331 | chr11 | 63904786:63905043:63908260:63908304:63908877:63909237 | 63908260:63908304 |
exon_skip_91246 | chr11 | 63904786:63905043:63906088:63906114:63908877:63909237 | 63906088:63906114 |
Differentially expressed PSI values of individual exon skipping events in multiple brain tissues between AD and control. |
Exon skipping information | Tissue type | Avg(PSIs) in AD | Avg(PSIs) in control | Difference (PSI) | Adj. p-value |
exon_skip_78331 | Mayo_CB | 3.352439e-01 | 4.923377e-01 | -1.570938e-01 | 1.197614e-05 |
Top |
Open reading frame (ORF) annotation in the exon skipping event for MARK2 |
Open reading frame (ORF) of individual exon skipping events in ROSMAP based on the Ensembl gene structure combined from isoforms. |
ENST | Start of skipped exon | End of skipped exon | ORF |
ENST00000402010 | 63900957 | 63901069 | Frame-shift |
ENST00000402010 | 63902601 | 63902782 | Frame-shift |
ENST00000402010 | 63903986 | 63904147 | In-frame |
ENST00000402010 | 63906088 | 63906114 | In-frame |
ENST00000402010 | 63908260 | 63908304 | In-frame |
Open reading frame (ORF) of individual exon skipping events in MSBB based on the Ensembl gene structure combined from isoforms. |
ENST | Start of skipped exon | End of skipped exon | ORF |
ENST00000402010 | 63903986 | 63904147 | In-frame |
ENST00000402010 | 63906088 | 63906114 | In-frame |
ENST00000402010 | 63908260 | 63908304 | In-frame |
Open reading frame (ORF) of individual exon skipping events in Mayo based on the Ensembl gene structure combined from isoforms. |
ENST | Start of skipped exon | End of skipped exon | ORF |
ENST00000402010 | 63898232 | 63898280 | Frame-shift |
ENST00000402010 | 63900957 | 63901069 | Frame-shift |
ENST00000402010 | 63902601 | 63902782 | Frame-shift |
ENST00000402010 | 63898608 | 63898673 | In-frame |
ENST00000402010 | 63903986 | 63904147 | In-frame |
ENST00000402010 | 63906088 | 63906114 | In-frame |
ENST00000402010 | 63908260 | 63908304 | In-frame |
Top |
Infer the effects of exon skipping event on protein functional features for MARK2 |
p-ENSG00000072518_img4.png |
Loci of skipped exons in ROSMAP across genomic, transcript, and protein sequence levels of In-frame cases. |
ENST | Length of mRNA | Length of AA seq. | Genomic start | Genomic end | mRNA start | mRNA end | AA start | AA end |
ENST00000402010 | 4745 | 788 | 63903986 | 63904147 | 2095 | 2255 | 505 | 558 |
ENST00000402010 | 4745 | 788 | 63908260 | 63908304 | 2542 | 2585 | 654 | 668 |
Loci of skipped exons in MSBB across genomic, transcript, and protein sequence levels of In-frame cases. |
ENST | Length of mRNA | Length of AA seq. | Genomic start | Genomic end | mRNA start | mRNA end | AA start | AA end |
ENST00000402010 | 4745 | 788 | 63903986 | 63904147 | 2095 | 2255 | 505 | 558 |
ENST00000402010 | 4745 | 788 | 63908260 | 63908304 | 2542 | 2585 | 654 | 668 |
Loci of skipped exons in Mayo across genomic, transcript, and protein sequence levels of In-frame cases. |
ENST | Length of mRNA | Length of AA seq. | Genomic start | Genomic end | mRNA start | mRNA end | AA start | AA end |
ENST00000402010 | 4745 | 788 | 63898608 | 63898673 | 918 | 982 | 113 | 134 |
ENST00000402010 | 4745 | 788 | 63903986 | 63904147 | 2095 | 2255 | 505 | 558 |
ENST00000402010 | 4745 | 788 | 63908260 | 63908304 | 2542 | 2585 | 654 | 668 |
Lost protein functional features of individual exon skipping events in ROSMAP. |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q7KZI7 | 505 | 558 | 505 | 558 | Alternative sequence | ID=VSP_051706;Note=In isoform 2%2C isoform 4%2C isoform 5%2C isoform 7%2C isoform 9%2C isoform 10%2C isoform 13%2C isoform 15 and isoform 16. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11433294,ECO:00 |
Q7KZI7 | 505 | 558 | 1 | 788 | Chain | ID=PRO_0000086301;Note=Serine/threonine-protein kinase MARK2 |
Q7KZI7 | 654 | 668 | 645 | 668 | Alternative sequence | ID=VSP_041853;Note=In isoform 15. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305 |
Q7KZI7 | 654 | 668 | 654 | 668 | Alternative sequence | ID=VSP_051708;Note=In isoform 5%2C isoform 11%2C isoform 10 and isoform 12. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11433294,ECO:0000303|PubMed:9730619,ECO:0000303|Ref.2;Dbxref=PMID:11433294,PMID:9730619 |
Q7KZI7 | 654 | 668 | 1 | 788 | Chain | ID=PRO_0000086301;Note=Serine/threonine-protein kinase MARK2 |
Lost protein functional features of individual exon skipping events in MSBB. |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q7KZI7 | 505 | 558 | 505 | 558 | Alternative sequence | ID=VSP_051706;Note=In isoform 2%2C isoform 4%2C isoform 5%2C isoform 7%2C isoform 9%2C isoform 10%2C isoform 13%2C isoform 15 and isoform 16. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11433294,ECO:00 |
Q7KZI7 | 505 | 558 | 1 | 788 | Chain | ID=PRO_0000086301;Note=Serine/threonine-protein kinase MARK2 |
Q7KZI7 | 654 | 668 | 645 | 668 | Alternative sequence | ID=VSP_041853;Note=In isoform 15. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305 |
Q7KZI7 | 654 | 668 | 654 | 668 | Alternative sequence | ID=VSP_051708;Note=In isoform 5%2C isoform 11%2C isoform 10 and isoform 12. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11433294,ECO:0000303|PubMed:9730619,ECO:0000303|Ref.2;Dbxref=PMID:11433294,PMID:9730619 |
Q7KZI7 | 654 | 668 | 1 | 788 | Chain | ID=PRO_0000086301;Note=Serine/threonine-protein kinase MARK2 |
Lost protein functional features of individual exon skipping events in Mayo. |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q7KZI7 | 113 | 134 | 115 | 120 | Beta strand | Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3IEC |
Q7KZI7 | 113 | 134 | 122 | 129 | Beta strand | Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3IEC |
Q7KZI7 | 113 | 134 | 1 | 788 | Chain | ID=PRO_0000086301;Note=Serine/threonine-protein kinase MARK2 |
Q7KZI7 | 113 | 134 | 53 | 304 | Domain | Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159 |
Q7KZI7 | 505 | 558 | 505 | 558 | Alternative sequence | ID=VSP_051706;Note=In isoform 2%2C isoform 4%2C isoform 5%2C isoform 7%2C isoform 9%2C isoform 10%2C isoform 13%2C isoform 15 and isoform 16. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11433294,ECO:00 |
Q7KZI7 | 505 | 558 | 1 | 788 | Chain | ID=PRO_0000086301;Note=Serine/threonine-protein kinase MARK2 |
Q7KZI7 | 654 | 668 | 645 | 668 | Alternative sequence | ID=VSP_041853;Note=In isoform 15. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305 |
Q7KZI7 | 654 | 668 | 654 | 668 | Alternative sequence | ID=VSP_051708;Note=In isoform 5%2C isoform 11%2C isoform 10 and isoform 12. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11433294,ECO:0000303|PubMed:9730619,ECO:0000303|Ref.2;Dbxref=PMID:11433294,PMID:9730619 |
Q7KZI7 | 654 | 668 | 1 | 788 | Chain | ID=PRO_0000086301;Note=Serine/threonine-protein kinase MARK2 |
Top |
3'-UTR located exon skipping events that lost miRNA binding sites in MARK2 |
3'-UTR exon skipping evnets lost miRNA binding. |
Tissue type | ENST | Exon skip start | Exon skip end | microRNA | Binding site by TargetScan | Binding type by TargetScan | Bdinding site by miRanda | Score of miRanda | Energy by miRanda |
Top |
SNVs in the skipped exons for MARK2 |
- Differential PSIs between mutated versus non-mutated samples. |
- Depth of Coverage in the skipped exon of the mutated samples. |
- Sashimi plot in the skipped exon of the mutated samples. |
- Non-synonymous mutations located in the skipped exons. |
Cancer type | Sample | ESID | Skipped exon start | Skipped exon end | Mutation start | Mutation end | Mutation type | Reference seq | Mutation seq | AAchange |
- Non-synonymous mutations located in the skipped exons in CCLE. |
Sample | Skipped exon start | Skipped exon end | Mutation start | Mutation end | Mutation type | Reference seq | Mutation seq | AAchange |
Top |
AD stage-associated exon skippint events for MARK2 |
Associated exon skipping events with Braak staging or Clinical Dementia Rating (CDR). |
AD stage info | Cohort | Tissue | SE id | Coefficient | P-value | Chromosome | Strand | E1 start | E1 end | Skipped start | Skipped end | E2 start | E2 end |
Top |
Splicing Quantitative Trait Loci (sQTL) in the exon skipping event for MARK2 |
sQTL information located at the skipped exons. |
Tissue type | Exon skip ID | SNP id | Location | P-value | FDR |
Top |
Correlation with RNA binding proteins (RBPs) for MARK2 |
Correlated RBP and related information. |
Tissue type | RBP name | Exon skip ID | Correlation coeifficient | P-value |
CB | CNOT4 | exon_skip_116275 | -4.336543e-01 | 1.129423e-08 |
CB | PCBP4 | exon_skip_116275 | 4.648662e-01 | 6.698872e-10 |
CB | TRA2A | exon_skip_91246 | -4.679452e-01 | 4.990538e-10 |
CB | NUP42 | exon_skip_91246 | 4.631784e-01 | 7.862343e-10 |
CB | TARDBP | exon_skip_78331 | -4.342362e-01 | 1.074237e-08 |
CB | TRA2A | exon_skip_78331 | -6.177972e-01 | 4.156659e-18 |
CB | NUP42 | exon_skip_78331 | 4.983905e-01 | 2.307250e-11 |
HCC | SFPQ | exon_skip_289284 | -4.446892e-01 | 1.817010e-14 |
HCC | RBM6 | exon_skip_289284 | -4.253032e-01 | 3.049649e-13 |
HCC | EIF4G2 | exon_skip_289284 | -4.181902e-01 | 8.211360e-13 |
IFG | PCBP4 | exon_skip_289284 | -4.520912e-01 | 1.572240e-02 |
IFG | TARDBP | exon_skip_78331 | -5.846955e-01 | 1.360194e-03 |
IFG | RBM5 | exon_skip_78331 | -5.190165e-01 | 5.536647e-03 |
IFG | TRA2A | exon_skip_78331 | -4.957997e-01 | 8.539413e-03 |
TC | NOVA1 | exon_skip_116275 | 4.721114e-01 | 2.931105e-10 |
Top |
RelatedDrugs for MARK2 |
Approved drugs targeting this gene. (DrugBank Version 5.1.0 2018-04-02) |
UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Q7KZI7 | approved|investigational | DB12010 | Fostamatinib | small molecule | Q7KZI7 |
Top |
RelatedDiseases for MARK2 |
Diseases associated with this gene. (DisGeNet 4.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |